Operationalization of COVID-19 Rapid Diagnosis Using Xpert® Xpress SARS CoV-2 Assay in Resource-Limited Settings: Early Implementation Lessons From Uganda

Abstract

Introduction: The novel Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) that causes COVID-19 disease is a global challenge. Several countries have adopted testing, isolation, and tracing strategy towards the control of the COVID-19 pandemic, but access to rapid and accurate testing is still a global challenge. The conventional PCR – based assay is the most commonly used test yet it has huge costs, infrastructural, and procurement logistical challenges. The Xpert® Xpress SARS-CoV-2 test is an automated in – vitro diagnostic test for the qualitative detection of nucleic acid from SARS-CoV-2 within a turnaround time of 60 minutes on the widely used GeneXpert Dx Instrument Systems. Here we document the best practices and challenges encountered with the operationalization of Xpert® Xpress SARS-CoV-2 testing in a resource-limited setting.Materials and Methods: The Xpert® Xpress SARS-CoV-2 implementation followed an operational work plan that included; Laboratory COVID-19 policy and planning, situational analysis of the Laboratory network, country Xpert® Xpress SARS-CoV-2 assay verification, and rollout at Mutukula Port Health Laboratory. The Laboratory strategy was based on a set of six objectives; conducting infrastructural modifications, building a strong COVID-19 testing capacity, developing robust Laboratory Quality and Information Management Systems, establishing a Bio-risk management and Bio-banking capacity.Results: The Xpert® Xpress SARS-CoV-2 testing implementation team that was appointed by the Ministry of Health (Uganda) successfully established the Xpert® Xpress SARS-CoV-2 testing Laboratory at Mutukula border in Uganda. As of 9th July 2020, this Laboratory had tested a total of 10,990 samples with a median turnaround time of 75 (IQR: 60 – 75) minutes for samples of persons entering through Mutukula Land Point of Entry as compared to the median TAT 1980 minutes before it was established. The laboratory had only one discordant result out of 20 panels in the inter-laboratory comparison retesting program.Conclusions: Implementation of Xpert® Xpress SARS-CoV-2 testing for rapid diagnosis of COVID-19 is feasible and significantly reduces the long TAT observed with conventional RT-PCR based testing. The operationalization of the Xpert® Xpress SARS-CoV-2 testing is largely dependent on the initial planning, adequacy of resources, and preparedness within the laboratory network. Challenges include; the difference in approaches to COVID-19 response, the attitude of truck-drivers/persons on Infection Prevention and Control measures, language barrier, and waste management issues.

Review of Laboratory Diagnostics Evolution in Nigeria's Response to Covid-19

“…The implementation of diagnostic procedures in the context of the COVID-19 pandemic has been fraught with numerous challenges and barriers, particularly in resource-limited settings. The global challenge of access to rapid and accurate testing has been exacerbated by infrastructural and logistical challenges, including supply chain shortages and the availability of testing centers (Nsawotebba et al, 2021). The Democratic Republic of Congo (DRC), for instance, has faced several exacerbating factors contributing to a poor healthcare system, including conflict, healthcare resource constraint and exhaustion, poor infrastructure, insufficient logistical resources, limited testing centers, and a lack of personal protective equipment (PPE).…”

“…In Uganda, the operationalization of Xpert® Xpress SARS-CoV-2 testing faced several challenges, including infrastructural modifications and the establishment of robust Laboratory Quality and Information Management Systems. Despite these challenges, the implementation team successfully established the Xpert® Xpress SARS-CoV-2 testing Laboratory, which significantly reduced the median turnaround time for samples compared to before it was established (Nsawotebba et al, 2021). The integration of innovative solutions such as machine learning methods with routinely available laboratory results can be useful when the relationship between individual analytes and disease state is complex or unknown.…”

Risk factors for disruptions in tuberculosis care in Uganda during the COVID-19 pandemic

“…A second 42-day lockdown was also instituted in April of 2021 with comparable, albeit less restrictive policies. During the initial lockdown period and initial phases of the pandemic TB testing platforms were repurposed to test for COVID-19 and TB clinic staff were affected by transportation restrictions and were reassigned to COVID-19 units leading to reports of understaffing [14,15]. Clinics also employed strategies to ensure continuation of essential TB services which included: financial incentives for healthcare workers, PPE distribution and dispensing medications for multiple months during refills [16].…”

Is diagnostic performance of SARS-CoV-2 detection dogs reduced -due to virus variation- over the time?

“…Studies showed that since up to 70% of patients, who were diagnosed with SARS-CoV-2 by RT-PCR, showed no or minimal symptoms, they pose a significant risk for spreading infection (Xu et al 2021). However, none of the currently used methods are reliable and/or applicable for mass screening of this infection in public places ( Martinez-Jimenez et al, 2021 , Nsawotebba et al, 2021 , Sharun et al 2020, Peeling et al 2021 ). The reverse transcription polymerase chain reaction (RT-PCR) test is a routine diagnostic tool to detect patients infected with SARS-CoV-2.…”